TrialArteriosclerosis, thrombosis, and vascular biology2018

PAR4 (Protease-Activated Receptor 4) Antagonism With BMS-986120 Inhibits Human Ex Vivo Thrombus Formation.

Simon J Wilson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.